These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Bonebridge implant in older children and adolescents with mixed or conductive hearing loss: Audiological outcomes. Ratuszniak A; Skarzynski PH; Gos E; Skarzynski H Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():97-102. PubMed ID: 30599287 [TBL] [Abstract][Full Text] [Related]
3. Active Transcutaneous Bone Conduction Implant: Middle Fossa Placement Technique in Children With Bilateral Microtia and External Auditory Canal Atresia. Der C; Bravo-Torres S; Pons N Otol Neurotol; 2018 Jun; 39(5):e342-e348. PubMed ID: 29664868 [TBL] [Abstract][Full Text] [Related]
4. Audiological outcomes in patients with congenital aural atresia implanted with transcutaneous active bone conduction hearing implant. Zernotti ME; Chiaraviglio MM; Mauricio SB; Tabernero PA; Zernotti M; Di Gregorio MF Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():54-58. PubMed ID: 30665177 [TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use. Schmerber S; Deguine O; Marx M; Van de Heyning P; Sterkers O; Mosnier I; Garin P; Godey B; Vincent C; Venail F; Mondain M; Deveze A; Lavieille JP; Karkas A Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1835-1851. PubMed ID: 27475796 [TBL] [Abstract][Full Text] [Related]
6. The BONEBRIDGE active transcutaneous bone conduction implant: effects of location, lifts and screws on sound transmission. Rohani SA; Bartling ML; Ladak HM; Agrawal SK J Otolaryngol Head Neck Surg; 2020 Aug; 49(1):58. PubMed ID: 32778163 [TBL] [Abstract][Full Text] [Related]
7. Retrosigmoid implantation of an active bone conduction stimulator in a patient with chronic otitis media. Lassaletta L; Sanchez-Cuadrado I; Muñoz E; Gavilan J Auris Nasus Larynx; 2014 Feb; 41(1):84-7. PubMed ID: 23722197 [TBL] [Abstract][Full Text] [Related]
8. Mastoid Dimensions in Children and Young Adults: Consequences for the Geometry of Transcutaneous Bone-Conduction Implants. Rahne T; Schilde S; Seiwerth I; Radetzki F; Stoevesandt D; Plontke SK Otol Neurotol; 2016 Jan; 37(1):57-61. PubMed ID: 26641261 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of unilateral and bilateral bimodal bone conduction hearing intervention in patients with bilateral microtia-atresia]. Niu XM; Ping L; Fan XM; Fan Y; Chen XW Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 56(4):346-350. PubMed ID: 33832192 [No Abstract] [Full Text] [Related]
10. Osseointegrated Auditory Devices: Bonebridge. Miller ME Otolaryngol Clin North Am; 2019 Apr; 52(2):265-272. PubMed ID: 30612757 [TBL] [Abstract][Full Text] [Related]
11. Indication criteria and outcomes with the Bonebridge transcutaneous bone-conduction implant. Riss D; Arnoldner C; Baumgartner WD; Blineder M; Flak S; Bachner A; Gstoettner W; Hamzavi JS Laryngoscope; 2014 Dec; 124(12):2802-6. PubMed ID: 25142577 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal economic analysis of Bonebridge 601 versus percutaneous bone-anchored hearing devices over a 5-year follow-up period. Amin N; Soulby AJ; Borsetto D; Pai I Clin Otolaryngol; 2021 Jan; 46(1):263-272. PubMed ID: 33068331 [TBL] [Abstract][Full Text] [Related]
13. Active transcutaneous bone conduction implant: audiological results in paediatric patients with bilateral microtia associated with external auditory canal atresia. Bravo-Torres S; Der-Mussa C; Fuentes-López E Int J Audiol; 2018 Jan; 57(1):53-60. PubMed ID: 28857620 [TBL] [Abstract][Full Text] [Related]
14. An experimental objective method to determine maximum output and dynamic range of an active bone conduction implant: the Bonebridge. Mertens G; Desmet J; Snik AF; Van de Heyning P Otol Neurotol; 2014 Aug; 35(7):1126-30. PubMed ID: 24662632 [TBL] [Abstract][Full Text] [Related]
15. Achondroplasia and severe sensorineural hearing loss: The role of active bone conduction implants. Siegel L; Araslanova R; Stepniak C; Zimmerman K; Agrawal SK Cochlear Implants Int; 2022 Sep; 23(5):291-299. PubMed ID: 35577761 [TBL] [Abstract][Full Text] [Related]
16. Adverse events associated with Bonebridge and Osia bone conduction implant devices. Crowder HR; Bestourous DE; Reilly BK Am J Otolaryngol; 2021; 42(4):102968. PubMed ID: 33676070 [TBL] [Abstract][Full Text] [Related]
17. The Bonebridge active bone conduction system: a fast and safe technique for a middle fossa approach. Carnevale C; Tomás-Barberán M; Til-Pérez G; Sarría-Echegaray P J Laryngol Otol; 2019 Apr; 133(4):344-347. PubMed ID: 30932803 [TBL] [Abstract][Full Text] [Related]
18. Use of a 3D reconstruction model in a patient with severe atresia auris for optimal placement of Bonebridge transcutaneous bone conduction implant. Della Volpe A; De Lucia A; Ippolito V; Pastore V; Iuppariello L; Formisano M; Clemente F; Di Stadio A Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3559-3564. PubMed ID: 33388989 [TBL] [Abstract][Full Text] [Related]
19. Individual computer-assisted 3D planning for placement of auricular prosthesis anchors in combination with an implantable transcutaneous bone conduction hearing device in patients with aural atresia. Seiwerth I; Plößl S; Herzog M; Schilde S; Radetzki F; Krämer S; Rahne T; Plontke SK HNO; 2023 Aug; 71(Suppl 1):1-9. PubMed ID: 36083471 [TBL] [Abstract][Full Text] [Related]
20. Planning tools and indications for "virtual surgery" for the Bonebridge bone conduction system. Seiwerth I; Schilde S; Wenzel C; Rahne T; Plontke SK HNO; 2021 Aug; 69(Suppl 2):39-46. PubMed ID: 33651113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]